349 related articles for article (PubMed ID: 26051715)
1. GTP-Dependent K-Ras Dimerization.
Muratcioglu S; Chavan TS; Freed BC; Jang H; Khavrutskii L; Freed RN; Dyba MA; Stefanisko K; Tarasov SG; Gursoy A; Keskin O; Tarasova NI; Gaponenko V; Nussinov R
Structure; 2015 Jul; 23(7):1325-35. PubMed ID: 26051715
[TBL] [Abstract][Full Text] [Related]
2. Oncogenic K-Ras4B Dimerization Enhances Downstream Mitogen-activated Protein Kinase Signaling.
Muratcioglu S; Aydin C; Odabasi E; Ozdemir ES; Firat-Karalar EN; Jang H; Tsai CJ; Nussinov R; Kavakli IH; Gursoy A; Keskin O
J Mol Biol; 2020 Feb; 432(4):1199-1215. PubMed ID: 31931009
[TBL] [Abstract][Full Text] [Related]
3. The higher level of complexity of K-Ras4B activation at the membrane.
Jang H; Banerjee A; Chavan TS; Lu S; Zhang J; Gaponenko V; Nussinov R
FASEB J; 2016 Apr; 30(4):1643-55. PubMed ID: 26718888
[TBL] [Abstract][Full Text] [Related]
4. Oncogenic and RASopathy-associated K-RAS mutations relieve membrane-dependent occlusion of the effector-binding site.
Mazhab-Jafari MT; Marshall CB; Smith MJ; Gasmi-Seabrook GM; Stathopulos PB; Inagaki F; Kay LE; Neel BG; Ikura M
Proc Natl Acad Sci U S A; 2015 May; 112(21):6625-30. PubMed ID: 25941399
[TBL] [Abstract][Full Text] [Related]
5. Regional polysterism in the GTP-bound form of the human c-Ha-Ras protein.
Ito Y; Yamasaki K; Iwahara J; Terada T; Kamiya A; Shirouzu M; Muto Y; Kawai G; Yokoyama S; Laue ED; Wälchli M; Shibata T; Nishimura S; Miyazawa T
Biochemistry; 1997 Jul; 36(30):9109-19. PubMed ID: 9230043
[TBL] [Abstract][Full Text] [Related]
6. Membrane-associated Ras dimers are isoform-specific: K-Ras dimers differ from H-Ras dimers.
Jang H; Muratcioglu S; Gursoy A; Keskin O; Nussinov R
Biochem J; 2016 Jun; 473(12):1719-32. PubMed ID: 27057007
[TBL] [Abstract][Full Text] [Related]
7. GTP Binding and Oncogenic Mutations May Attenuate Hypervariable Region (HVR)-Catalytic Domain Interactions in Small GTPase K-Ras4B, Exposing the Effector Binding Site.
Lu S; Banerjee A; Jang H; Zhang J; Gaponenko V; Nussinov R
J Biol Chem; 2015 Nov; 290(48):28887-900. PubMed ID: 26453300
[TBL] [Abstract][Full Text] [Related]
8. Different structural requirements within the switch II region of the Ras protein for interactions with specific downstream targets.
Moodie SA; Paris M; Villafranca E; Kirshmeier P; Willumsen BM; Wolfman A
Oncogene; 1995 Aug; 11(3):447-54. PubMed ID: 7630628
[TBL] [Abstract][Full Text] [Related]
9. Allosteric effects of the oncogenic RasQ61L mutant on Raf-RBD.
Fetics SK; Guterres H; Kearney BM; Buhrman G; Ma B; Nussinov R; Mattos C
Structure; 2015 Mar; 23(3):505-516. PubMed ID: 25684575
[TBL] [Abstract][Full Text] [Related]
10. A structural model of a Ras-Raf signalosome.
Mysore VP; Zhou ZW; Ambrogio C; Li L; Kapp JN; Lu C; Wang Q; Tucker MR; Okoro JJ; Nagy-Davidescu G; Bai X; Plückthun A; Jänne PA; Westover KD; Shan Y; Shaw DE
Nat Struct Mol Biol; 2021 Oct; 28(10):847-857. PubMed ID: 34625747
[TBL] [Abstract][Full Text] [Related]
11. Membrane Composition and Raf[CRD]-Membrane Attachment Are Driving Forces for K-Ras4B Dimer Stability.
Andreadelis I; Kiriakidi S; Lamprakis C; Theodoropoulou A; Doerr S; Chatzigoulas A; Manchester J; Velez-Vega C; Duca JS; Cournia Z
J Phys Chem B; 2022 Feb; 126(7):1504-1519. PubMed ID: 35142524
[TBL] [Abstract][Full Text] [Related]
12. Peptides containing a consensus Ras binding sequence from Raf-1 and theGTPase activating protein NF1 inhibit Ras function.
Clark GJ; Drugan JK; Terrell RS; Bradham C; Der CJ; Bell RM; Campbell S
Proc Natl Acad Sci U S A; 1996 Feb; 93(4):1577-81. PubMed ID: 8643674
[TBL] [Abstract][Full Text] [Related]
13. High-Affinity Interaction of the K-Ras4B Hypervariable Region with the Ras Active Site.
Chavan TS; Jang H; Khavrutskii L; Abraham SJ; Banerjee A; Freed BC; Johannessen L; Tarasov SG; Gaponenko V; Nussinov R; Tarasova NI
Biophys J; 2015 Dec; 109(12):2602-2613. PubMed ID: 26682817
[TBL] [Abstract][Full Text] [Related]
14. The small GTPases K-Ras, N-Ras, and H-Ras have distinct biochemical properties determined by allosteric effects.
Johnson CW; Reid D; Parker JA; Salter S; Knihtila R; Kuzmic P; Mattos C
J Biol Chem; 2017 Aug; 292(31):12981-12993. PubMed ID: 28630043
[TBL] [Abstract][Full Text] [Related]
15. Improved binding of raf to Ras.GDP is correlated with biological activity.
Kiel C; Filchtinski D; Spoerner M; Schreiber G; Kalbitzer HR; Herrmann C
J Biol Chem; 2009 Nov; 284(46):31893-902. PubMed ID: 19776012
[TBL] [Abstract][Full Text] [Related]
16. Conformational Dynamics Allows Sampling of an "Active-like" State by Oncogenic K-Ras-GDP.
Grudzien P; Jang H; Leschinsky N; Nussinov R; Gaponenko V
J Mol Biol; 2022 Sep; 434(17):167695. PubMed ID: 35752212
[TBL] [Abstract][Full Text] [Related]
17. Raf-1 is involved in the regulation of the interaction between guanine nucleotide exchange factor and Ha-ras. Evidences for a function of Raf-1 and phosphatidylinositol 3-kinase upstream to Ras.
Giglione C; Parmeggiani A
J Biol Chem; 1998 Dec; 273(52):34737-44. PubMed ID: 9856997
[TBL] [Abstract][Full Text] [Related]
18. The RAS-Effector Interface: Isoform-Specific Differences in the Effector Binding Regions.
Nakhaeizadeh H; Amin E; Nakhaei-Rad S; Dvorsky R; Ahmadian MR
PLoS One; 2016; 11(12):e0167145. PubMed ID: 27936046
[TBL] [Abstract][Full Text] [Related]
19. RAS/Effector Interactions from Structural and Biophysical Perspective.
Erijman A; Shifman JM
Mini Rev Med Chem; 2016; 16(5):370-5. PubMed ID: 26423700
[TBL] [Abstract][Full Text] [Related]
20. COMBINE analysis of the specificity of binding of Ras proteins to their effectors.
Tomić S; Bertosa B; Wang T; Wade RC
Proteins; 2007 May; 67(2):435-47. PubMed ID: 17295314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
